CEPHEID IN(NSDQ:CPHD)
|
Cepheid, Inc. develops, manufactures and markets microfluidic systems that integrate, automate and accelerate biological testing. Their systems are miniaturized instruments that analyze complex biological samples in a disposable cartridge by combining molecular biology with microfluidic technology that processes small quantities of liquid, typically using components fabricated with computer chip technology. These systems rapidly perform all of the steps required to analyze complex biological samples.
|
# Employees: 473
|
|
Address: 904 Caribbean Drive,Sunnyvale,CA,USA
|
|
Phone: 408 541-4191
|
Fax: 408 541-4192
|
|
Website: www.cepheid.com
|
Email: jspark@pnlifesciences.com
|
Sector: Medical
|
Industry: MED INSTRUMENTS
|
Executive Officers
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
|
Last Earnings Date: 9/30/2008
|
|
Next Earnings Date(Expected): 2/19/2009
|
|
Mean EPS (Next Qtr): ($0.09)
|
|
Mean EPS (Year): ($0.23)
|
|
Mean Estimate(Long Term): $15.00
|
|
P/E Ratio(Based on EPS estimate): -0.010
|
|
Number of Estimates: 11
|
|
Shares Performance
|
Period
|
CPHD
|
Compare to S&P
|
| YTD |
2.60 %
|
-2.04 %
|
| 4 Weeks |
0.85 %
|
-4.11 %
|
| 12 Weeks |
-5.92 %
|
0.45 %
|
Shares Information
|
Analyst Coverage: Y
|
Avg Volume: 533551
|
|
Shares Outstanding: 57M
|
Market Cap: $0.61B
|
| 52 Week High: $32.34
|
52 Week Low: $9.16
|
| P/E Ratio: -0.010
|
PEG Ratio: -0.010
|
|
Split: On 1/1/1990 CPHD split by factor of 0.100
|
Earnings Performance
EPS Growth in Last Quarter: 15.38 %
EPS Growth in Last Year: -22.22 %
Sales Growth in Last Quarter: 15.31 %
Sales Growth in Last Quarter: 32.04 %
Financials
|
Qtr Book Value: $4.70
|
|
Cash Flow/Share: ($0.01)
|
|
Change in Payout Ratio: -0.010
|
|
Price/Sales: -0.010
|
|
